PA
RILY icon

PharVision Advisers’s BRC Group Holdings RILY Stock Holding History

PharVision Advisers’s Portfolio RILY Stock Details RILY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,149
Closed -$81.6K – 117
2026
Q1 		$81.6K Sell
11,149
-43,619
-80% -$325K 0.83% 63
2025
Q4 		$256K Buy
+54,768
New +$271K 0.13% 381

Other funds holding RILY

EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
DT
DBA Trading Fort Lauderdale, Florida $199M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PharVision Advisers's RILY Position: Q2 2026 in Review

PharVision Advisers sold out of BRC Group Holdings (RILY) in Q2 2026, closing a stake of 11,149 shares — an estimated $81.6K sold.

PharVision Advisers first reported a position in RILY in Q4 2025 and held it in 2 quarters. The position peaked at $256K in Q4 2025. 93 funds tracked by Wall St. Rank hold RILY as of Q2 2026.

  • PharVision Advisers reported no remaining BRC Group Holdings position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,149 BRC Group Holdings shares in Q2 2026, an estimated $81.6K.
  • PharVision Advisers first reported a position in BRC Group Holdings in Q4 2025 and held it in 2 quarters.
  • PharVision Advisers's BRC Group Holdings position peaked at $256K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held BRC Group Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.